
HLI
Houlihan Lokey Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
191.010
Open
188.870
VWAP
190.27
Vol
277.84K
Mkt Cap
13.39B
Low
188.870
Amount
52.86M
EV/EBITDA(TTM)
20.06
Total Shares
68.58M
EV
12.50B
EV/OCF(TTM)
16.00
P/S(TTM)
5.23
Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Its segments include Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA). CF segment provides general financial advisory services and advice on mergers and acquisitions and capital solutions offerings. FR segment offers a range of advisory services to its clients, including: the structuring, negotiation, and confirmation of plans of reorganization; liability management transactions; corporate viability assessment, and procuring debtor-in-possession financing. FVA segment provides financial advisory and valuation services with respect to companies, debt and equity interests (including complex illiquid investments), and other types of assets and liabilities, and others. It also provides investment banking advice to clients in the insurance and wealth management sectors.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q4
FY2026Q3
FY2026Q2
731.75M
+9.8%
1.990
+1.53%
710.02M
+11.92%
1.906
+16.2%
638.32M
+11.02%
1.643
+12.52%
Estimates Revision
The market is revising Upward the revenue expectations for Houlihan Lokey, Inc. (HLI) for FY2026, with the revenue forecasts being adjusted by 2.6% over the past three months. During the same period, the stock price has changed by 7.08%.
Revenue Estimates for FY2026
Revise Upward

+2.6%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward

+8.31%
In Past 3 Month
Stock Price
Go Up

+7.08%
In Past 3 Month
6 Analyst Rating

3.53% Upside
Wall Street analysts forecast HLI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLI is 197.17 USD with a low forecast of 162.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
1 Sell
Moderate Buy

3.53% Upside
Current: 190.450

Low
162.00
Averages
197.17
High
232.00

3.53% Upside
Current: 190.450

Low
162.00
Averages
197.17
High
232.00
Keefe Bruyette
Alex Bond
Market Perform -> Outperform
upgrade
$185 -> $232
2025-07-13
Reason
Keefe Bruyette
Alex Bond
Price Target
$185 -> $232
2025-07-13
upgrade
Market Perform -> Outperform
Reason
Keefe Bruyette analyst Alex Bond upgraded Houlihan Lokey to Outperform from Market Perform with a price target of $232, up from $185, following a transfer of coverage. The firm believes the merger and acquisition environment should continue to improve gradually throughout the second half of the year. While policy and geopolitical uncertainty remain a risk, deal pipelines are still near all-time highs, the analyst tells investors in a research note.
Wolfe Research
Underperform
maintain
$151 -> $162
2025-07-10
Reason
Wolfe Research
Price Target
$151 -> $162
2025-07-10
maintain
Underperform
Reason
Wolfe Research raised the firm's price target on Houlihan Lokey to $162 from $151 and keeps an Underperform rating on the shares. The firm has confidence in recommending alternative asset managers over the merger and acquisition brokers as a way to play the improving capital markets backdrop.
Morgan Stanley
Overweight
maintain
$159 -> $192
2025-06-23
Reason
Morgan Stanley
Price Target
$159 -> $192
2025-06-23
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on Houlihan Lokey to $192 from $159 and keeps an Overweight rating on the shares. The firm, which raised its Midcap Advisors Industry View to In-Line due to improving market conditions for dealmaking, expects the pipeline to start moving again, driven by rapidly improving market conditions, regulatory clarity, significant pent-up demand, and structural drivers of M&A, the analyst tells investors in a group note.
Keefe Bruyette
Market Perform
maintain
$183 -> $185
2025-05-12
Reason
Keefe Bruyette
Price Target
$183 -> $185
2025-05-12
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Houlihan Lokey to $185 from $183 and keeps a Market Perform rating on the shares. Messaging was relatively consistent across the industry as the recent market volatility has led to a slowdown in completed deals, but management teams remain upbeat, the analyst tells investors in a research note.
Wells Fargo
Overweight
maintain
$170 -> $185
2025-05-08
Reason
Wells Fargo
Price Target
$170 -> $185
2025-05-08
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Houlihan Lokey to $185 from $170 and keeps an Overweight rating on the shares. The firm says the defense and offense delivered this quarter, with all three businesses topping consensus. Commentary suggests pace of activity still chugging along fine and RX outlook bright, Wells adds.
Wells Fargo
Michael Brown
Buy
Maintains
$179 → $170
2025-04-08
Reason
Wells Fargo
Michael Brown
Price Target
$179 → $170
2025-04-08
Maintains
Buy
Reason
Wells Fargo analyst Michael Brown lowered the firm's price target on Houlihan Lokey to $170 from $179 and keeps an Overweight rating on the shares. The firm says that Q1 results should be decent for the asset managers/brokers group, but the focus is now on what's to come. In Wells' coverage, there are few places to hide from the tariff storm. Alts are nearing levels that are tough to ignore, but stocks can overshoot to the downside, the firm adds.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Houlihan Lokey Inc (HLI.N) is 24.99, compared to its 5-year average forward P/E of 20.35. For a more detailed relative valuation and DCF analysis to assess Houlihan Lokey Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued
5Y Average PE
20.35
Current PE
24.99
Overvalued PE
24.71
Undervalued PE
15.99
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued
5Y Average PS
3.65
Current PS
4.82
Overvalued PS
4.37
Undervalued PS
2.92
Financials
Annual
Quarterly
FY2026Q1
YoY :
+17.86%
605.35M
Total Revenue
FY2026Q1
YoY :
+16.78%
128.24M
Operating Profit
FY2026Q1
YoY :
+9.66%
97.53M
Net Income after Tax
FY2026Q1
YoY :
+9.23%
1.42
EPS - Diluted
FY2026Q1
YoY :
+92.11%
-144.82M
Free Cash Flow
FY2026Q1
YoY :
+78.66%
29.80
FCF Margin - %
FY2026Q1
YoY :
-6.99%
16.11
Net Margin - %
FY2026Q1
YoY :
+14.03%
20.24
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
1.1M
USD
4
3-6
Months
1.5M
USD
4
6-9
Months
105.0K
USD
3
0-12
Months
4.0M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 102.34% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
462.4K
Volume
3
6-9
Months
228.5K
Volume
4
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
23.8K
Volume
Months
6-9
1
19.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areSelling! The selling amount has increased100%over the last month.
Sold
0-3
Months
16.0K
USD
2
3-6
Months
8.0K
USD
1
6-9
Months
75.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
1.1M
USD
4
3-6
Months
1.5M
USD
4
6-9
Months
105.0K
USD
3
0-12
Months
4.0M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
HLI News & Events
Events Timeline
2025-07-29 (ET)
2025-07-29
16:17:52
Houlihan Lokey reports Q1 adjusted EPS $2.14, consensus $1.68

2025-06-02 (ET)
2025-06-02
09:20:25
Houlihan Lokey announces Rogowski joined as Managing Director

2025-05-07 (ET)
2025-05-07
17:27:14
Houlihan Lokey raises quarterly dividend 5% to 60c per share

Sign Up For More Events
Sign Up For More Events
News
6.5
08-04NASDAQ.COMHere is Why Growth Investors Should Buy Houlihan Lokey (HLI) Now
4.0
08-04NASDAQ.COMNew Strong Buy Stocks for August 4th
9.5
07-31NASDAQ.COMHoulihan Lokey (HLI) Q1 EPS Jumps 75%
Sign Up For More News
People Also Watch

JKHY
Jack Henry & Associates Inc
158.520
USD
-1.88%

SOLV
Solventum Corp
71.860
USD
-2.08%

AR
Antero Resources Corp
32.400
USD
-1.25%

BJ
BJ's Wholesale Club Holdings Inc
107.440
USD
-0.63%

RDY
Dr Reddy's Laboratories Ltd
13.820
USD
+0.14%

ELS
Equity LifeStyle Properties Inc
59.860
USD
-0.48%

GMED
Globus Medical Inc
59.430
USD
+1.33%

JLL
Jones Lang LaSalle Inc
275.790
USD
-0.87%

THC
Tenet Healthcare Corp
166.630
USD
+0.63%
FAQ

What is Houlihan Lokey Inc (HLI) stock price today?
The current price of HLI is 190.45 USD — it has increased 0.83 % in the last trading day.

What is Houlihan Lokey Inc (HLI)'s business?

What is the price predicton of HLI Stock?

What is Houlihan Lokey Inc (HLI)'s revenue for the last quarter?

What is Houlihan Lokey Inc (HLI)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Houlihan Lokey Inc (HLI)'s fundamentals?

How many employees does Houlihan Lokey Inc (HLI). have?
